Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis

Jungwon Huh, Ramon V. Tiu, Lukasz P. Gondek, Christine L. O'Keefe, Monika Jasek, Hideki Makishima, Ania M. Jankowska, Ying Jiang, Amit K. Verma, Karl S. Theil, Michael A. McDevitt, Jaroslaw P. Maciejewski

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Deletion of the long arm of chromosome 20 is a common abnormality associated with myeloid malignancies. We characterized abnormalities of chromosome 20 as defined by metaphase cytogenetics (MC) in patients with myeloid neoplasms to define commonly deleted regions (CDR) and commonly retained regions (CRR) using genome-wide, high resolution single nucleotide polymorphism array (SNP-A) analysis. We reviewed the MC results of a cohort of 1,162 patients with myeloid malignancies, including myelodysplastic syndromes (MDS), MDS/myeloproliferative neoplasia (MDS/MPN), and acute myeloid leukemia (AML). We further analyzed a subcohort of 532 patients by SNP-A using the Affymetrix Genome-Wide Human SNP Array 6.0 and GeneChip Human Mapping 250K Nsp arrays. By MC, 5% (54/1,162) harbored a deletion of 20q; in 30% (16/54), del(20q) was the sole cytogenetic abnormality. By SNP-A analysis, we identified del(20q) in 23 patients, 3 not detected by MC. In four cases, monosomy 20 with a marker chromosome by MC was proven to be an interstitial deletion of 20q by SNP-A. We defined 2 CDR and 2 CRR on chromosome arm 20q: CDR1 spanned 2.5 Mb between bands 20q11.23 and 20q12, while CDR2 encompassed 1.8 Mb within 20q13.12. CRR1 spanned 1.9 Mb within 20q11.21 and CRR2 encompassed 2.5 Mb within 20q13.33. In contrast to other chromosomes frequently affected by deletions, no somatic copy neutral loss of heterozygosity (CN-LOH) was detected. Our data suggest that SNP-A is useful for the detection of cryptic aberrations of chromosome 20q and allows for a more precise characterization of complex karyotypes. Furthermore, SNP-A allowed definition of a CDR on 20q.

Original languageEnglish (US)
Pages (from-to)390-399
Number of pages10
JournalGenes Chromosomes and Cancer
Volume49
Issue number4
DOIs
StatePublished - Apr 2010

Fingerprint

Single Nucleotide Polymorphism
Chromosomes
Metaphase
Genome
Cytogenetics
Neoplasms
Chromosomes, Human, Pair 20
Myelodysplastic Syndromes
Chromosome Aberrations
Monosomy
Loss of Heterozygosity
Human Genome
Karyotype
Genetic Markers
Acute Myeloid Leukemia

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. / Huh, Jungwon; Tiu, Ramon V.; Gondek, Lukasz P.; O'Keefe, Christine L.; Jasek, Monika; Makishima, Hideki; Jankowska, Ania M.; Jiang, Ying; Verma, Amit K.; Theil, Karl S.; McDevitt, Michael A.; Maciejewski, Jaroslaw P.

In: Genes Chromosomes and Cancer, Vol. 49, No. 4, 04.2010, p. 390-399.

Research output: Contribution to journalArticle

Huh, J, Tiu, RV, Gondek, LP, O'Keefe, CL, Jasek, M, Makishima, H, Jankowska, AM, Jiang, Y, Verma, AK, Theil, KS, McDevitt, MA & Maciejewski, JP 2010, 'Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis', Genes Chromosomes and Cancer, vol. 49, no. 4, pp. 390-399. https://doi.org/10.1002/gcc.20748
Huh, Jungwon ; Tiu, Ramon V. ; Gondek, Lukasz P. ; O'Keefe, Christine L. ; Jasek, Monika ; Makishima, Hideki ; Jankowska, Ania M. ; Jiang, Ying ; Verma, Amit K. ; Theil, Karl S. ; McDevitt, Michael A. ; Maciejewski, Jaroslaw P. / Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. In: Genes Chromosomes and Cancer. 2010 ; Vol. 49, No. 4. pp. 390-399.
@article{ef61429decf64a2bbfd25a86ede68fc7,
title = "Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis",
abstract = "Deletion of the long arm of chromosome 20 is a common abnormality associated with myeloid malignancies. We characterized abnormalities of chromosome 20 as defined by metaphase cytogenetics (MC) in patients with myeloid neoplasms to define commonly deleted regions (CDR) and commonly retained regions (CRR) using genome-wide, high resolution single nucleotide polymorphism array (SNP-A) analysis. We reviewed the MC results of a cohort of 1,162 patients with myeloid malignancies, including myelodysplastic syndromes (MDS), MDS/myeloproliferative neoplasia (MDS/MPN), and acute myeloid leukemia (AML). We further analyzed a subcohort of 532 patients by SNP-A using the Affymetrix Genome-Wide Human SNP Array 6.0 and GeneChip Human Mapping 250K Nsp arrays. By MC, 5{\%} (54/1,162) harbored a deletion of 20q; in 30{\%} (16/54), del(20q) was the sole cytogenetic abnormality. By SNP-A analysis, we identified del(20q) in 23 patients, 3 not detected by MC. In four cases, monosomy 20 with a marker chromosome by MC was proven to be an interstitial deletion of 20q by SNP-A. We defined 2 CDR and 2 CRR on chromosome arm 20q: CDR1 spanned 2.5 Mb between bands 20q11.23 and 20q12, while CDR2 encompassed 1.8 Mb within 20q13.12. CRR1 spanned 1.9 Mb within 20q11.21 and CRR2 encompassed 2.5 Mb within 20q13.33. In contrast to other chromosomes frequently affected by deletions, no somatic copy neutral loss of heterozygosity (CN-LOH) was detected. Our data suggest that SNP-A is useful for the detection of cryptic aberrations of chromosome 20q and allows for a more precise characterization of complex karyotypes. Furthermore, SNP-A allowed definition of a CDR on 20q.",
author = "Jungwon Huh and Tiu, {Ramon V.} and Gondek, {Lukasz P.} and O'Keefe, {Christine L.} and Monika Jasek and Hideki Makishima and Jankowska, {Ania M.} and Ying Jiang and Verma, {Amit K.} and Theil, {Karl S.} and McDevitt, {Michael A.} and Maciejewski, {Jaroslaw P.}",
year = "2010",
month = "4",
doi = "10.1002/gcc.20748",
language = "English (US)",
volume = "49",
pages = "390--399",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis

AU - Huh, Jungwon

AU - Tiu, Ramon V.

AU - Gondek, Lukasz P.

AU - O'Keefe, Christine L.

AU - Jasek, Monika

AU - Makishima, Hideki

AU - Jankowska, Ania M.

AU - Jiang, Ying

AU - Verma, Amit K.

AU - Theil, Karl S.

AU - McDevitt, Michael A.

AU - Maciejewski, Jaroslaw P.

PY - 2010/4

Y1 - 2010/4

N2 - Deletion of the long arm of chromosome 20 is a common abnormality associated with myeloid malignancies. We characterized abnormalities of chromosome 20 as defined by metaphase cytogenetics (MC) in patients with myeloid neoplasms to define commonly deleted regions (CDR) and commonly retained regions (CRR) using genome-wide, high resolution single nucleotide polymorphism array (SNP-A) analysis. We reviewed the MC results of a cohort of 1,162 patients with myeloid malignancies, including myelodysplastic syndromes (MDS), MDS/myeloproliferative neoplasia (MDS/MPN), and acute myeloid leukemia (AML). We further analyzed a subcohort of 532 patients by SNP-A using the Affymetrix Genome-Wide Human SNP Array 6.0 and GeneChip Human Mapping 250K Nsp arrays. By MC, 5% (54/1,162) harbored a deletion of 20q; in 30% (16/54), del(20q) was the sole cytogenetic abnormality. By SNP-A analysis, we identified del(20q) in 23 patients, 3 not detected by MC. In four cases, monosomy 20 with a marker chromosome by MC was proven to be an interstitial deletion of 20q by SNP-A. We defined 2 CDR and 2 CRR on chromosome arm 20q: CDR1 spanned 2.5 Mb between bands 20q11.23 and 20q12, while CDR2 encompassed 1.8 Mb within 20q13.12. CRR1 spanned 1.9 Mb within 20q11.21 and CRR2 encompassed 2.5 Mb within 20q13.33. In contrast to other chromosomes frequently affected by deletions, no somatic copy neutral loss of heterozygosity (CN-LOH) was detected. Our data suggest that SNP-A is useful for the detection of cryptic aberrations of chromosome 20q and allows for a more precise characterization of complex karyotypes. Furthermore, SNP-A allowed definition of a CDR on 20q.

AB - Deletion of the long arm of chromosome 20 is a common abnormality associated with myeloid malignancies. We characterized abnormalities of chromosome 20 as defined by metaphase cytogenetics (MC) in patients with myeloid neoplasms to define commonly deleted regions (CDR) and commonly retained regions (CRR) using genome-wide, high resolution single nucleotide polymorphism array (SNP-A) analysis. We reviewed the MC results of a cohort of 1,162 patients with myeloid malignancies, including myelodysplastic syndromes (MDS), MDS/myeloproliferative neoplasia (MDS/MPN), and acute myeloid leukemia (AML). We further analyzed a subcohort of 532 patients by SNP-A using the Affymetrix Genome-Wide Human SNP Array 6.0 and GeneChip Human Mapping 250K Nsp arrays. By MC, 5% (54/1,162) harbored a deletion of 20q; in 30% (16/54), del(20q) was the sole cytogenetic abnormality. By SNP-A analysis, we identified del(20q) in 23 patients, 3 not detected by MC. In four cases, monosomy 20 with a marker chromosome by MC was proven to be an interstitial deletion of 20q by SNP-A. We defined 2 CDR and 2 CRR on chromosome arm 20q: CDR1 spanned 2.5 Mb between bands 20q11.23 and 20q12, while CDR2 encompassed 1.8 Mb within 20q13.12. CRR1 spanned 1.9 Mb within 20q11.21 and CRR2 encompassed 2.5 Mb within 20q13.33. In contrast to other chromosomes frequently affected by deletions, no somatic copy neutral loss of heterozygosity (CN-LOH) was detected. Our data suggest that SNP-A is useful for the detection of cryptic aberrations of chromosome 20q and allows for a more precise characterization of complex karyotypes. Furthermore, SNP-A allowed definition of a CDR on 20q.

UR - http://www.scopus.com/inward/record.url?scp=77949372605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949372605&partnerID=8YFLogxK

U2 - 10.1002/gcc.20748

DO - 10.1002/gcc.20748

M3 - Article

C2 - 20095039

AN - SCOPUS:77949372605

VL - 49

SP - 390

EP - 399

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 4

ER -